Target intelligence / Profile preview

Autophagy pathway machinery

Molecular classification
Enzyme, Protein complex, Signaling pathway, Ligase, Kinase
01

Overview

The autophagy pathway machinery refers to the highly conserved network of proteins and signaling cascades responsible for macroautophagy, a fundamental process for the degradation and recycling of cytoplasmic components (Mizushima & Komatsu, 2011). This machinery is orchestrated by autophagy-related (ATG) proteins that form functional complexes to manage the initiation, nucleation, elongation, and lysosomal fusion stages of autophagosome development (Galluzzi et al., 2017). Under physiological conditions, this system maintains cellular homeostasis by removing damaged organelles and protein aggregates, but its dysregulation is a hallmark of various diseases (Levine & Kroemer, 2019). In neurodegenerative disorders, the machinery is often insufficient to clear toxic protein aggregates, whereas in cancer, it can act as a tumor suppressor in early stages or a survival mechanism for established tumors under metabolic stress (Levine & Kroemer, 2019). Therapeutic strategies target specific nodes of this machinery, such as using mTOR inhibitors to induce autophagy for neuroprotection or lysosomotropic agents to inhibit it in oncology (Klionsky et al., 2021). Monitoring the efficacy of these interventions typically involves assessing the conversion of LC3-I to LC3-II or the accumulation of the cargo adapter p62 (Klionsky et al., 2021).

Other names
Macroautophagy pathwayAutophagic machineryAutophagy-related protein systemATG system
02

Mechanism of action

Modulation of the autophagy pathway machinery occurs through several distinct mechanisms: mTORC1 inhibitors (e.g., Rapamycin) relieve the suppression of the ULK1 initiation complex to induce autophagosome formation (Mizushima & Komatsu, 2011); class III PI3K inhibitors (e.g., SAR405) prevent the nucleation of the phagophore by blocking VPS34 activity (Galluzzi et al., 2017); and lysosomotropic agents (e.g., Hydroxychloroquine) inhibit the final stage of the pathway by increasing lysosomal pH, which prevents the fusion of autophagosomes with lysosomes and the subsequent degradation of cargo (Klionsky et al., 2021).

03

Biological functions

Cellular homeostasisProtein degradationOrganelle recyclingStress responseCell deathImmune response
04

Disease associations

CancerNeurodegenerative diseaseInfectionInflammationCardiovascular diseaseMetabolic disorder
05

Safety considerations

Dual role in cancer (potential to promote tumor survival and chemoresistance in established tumors)Systemic toxicity due to the ubiquitous nature of autophagy in healthy tissuesPotential for immunosuppressionRisk of impairing normal cellular clearance in long-lived cells like neuronsOff-target effects of broad-spectrum inhibitors like hydroxychloroquine
06

Interacting drugs

Rapamycin (Sirolimus)

7 more in the full profile.

07

Biomarkers

Microtubule-associated protein 1 light chain 3B (LC3-II)Sequestosome-1 (p62/SQSTM1)Beclin-1Autophagy-related protein 5 (ATG5)Autophagy-related protein 12 (ATG12)

Beyond the preview

Go deeper on Autophagy pathway machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Autophagy pathway machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call